These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21206344)

  • 1. Lipid metabolism.
    Young IS; Nicholls DP
    Curr Opin Lipidol; 2010 Dec; 21(6):550-1. PubMed ID: 21206344
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.
    Rocha MP; Maranhão RC; Seydell TM; Barcellos CR; Baracat EC; Hayashida SA; Bydlowski SP; Marcondes JA
    Fertil Steril; 2010 Apr; 93(6):1948-56. PubMed ID: 19765700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic aspects of polycystic ovary syndrome.
    Wild RA
    Semin Reprod Endocrinol; 1997 May; 15(2):105-10. PubMed ID: 9165655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathomechanism of polycystic ovary syndrome in the light of recent research findings].
    Károlyi Z
    Orv Hetil; 2012 Oct; 153(40):1567-9. PubMed ID: 23022879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology and types of dyslipidemia in PCOS.
    Diamanti-Kandarakis E; Papavassiliou AG; Kandarakis SA; Chrousos GP
    Trends Endocrinol Metab; 2007 Sep; 18(7):280-5. PubMed ID: 17692530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome in women.
    Schneider JG; Tompkins C; Blumenthal RS; Mora S
    Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
    Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance and infertility].
    Koivunen R; Morin-Papunen L
    Duodecim; 2002; 118(5):509-15. PubMed ID: 12232991
    [No Abstract]   [Full Text] [Related]  

  • 16. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in women with polycystic ovary syndrome.
    Essah PA; Nestler JE
    Fertil Steril; 2006 Jul; 86 Suppl 1():S18-9. PubMed ID: 16798277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study.
    Romualdi D; Costantini B; Campagna G; Lanzone A; Guido M
    Fertil Steril; 2008 Nov; 90(5):1826-33. PubMed ID: 18166189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.